The signaling molecules Akt, Ras, and AMPK can induce lactate production by activating glycolysis to cause the Warburg effect, prompting tumor cells to meet energy demand through Gln metabolism
Clinical trials show weight loss between 15% and 21% for GLP-1s, but this study suggests that real-world outcomes are much lower, said Dr
Studies are also underway to assess the efficacy of GLP1s for: Addiction: Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity (Scientific Reports, Nature), Semaglutide for Alcohol Use Disorder (Phase II clinical trial by UNC) Alzheimer's: The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimers disease (Frontiers in Endocrinology) Mental Health & Suicidal Ideation: Most GLP-1 Medications Correlated with a Lower Likelihood of Anxiety and Depression Diagnoses (Epic Research) Alcohol-related liver disease ( Novo Nordisk clinical trial ) Osteoarthritis ( STEP 9 ) Metabolic dysfunction-associated steatohepatitis (MASH): Tirzepatide for Metabolic DysfunctionAssociated Steatohepatitis with Liver Fibrosis This is just the beginning
The FDA has conducted thorough reviews of cancer-related safety data for all approved GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists
This is a finding that should be investigated, not ignored
